Receive News & Ratings for Bayer AG Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Bayer AG (BAYN) PT Set at €130.00 by BNP Paribas

Bayer AG (FRA:BAYN) has been given a €130.00 ($154.76) target price by analysts at BNP Paribas in a report issued on Monday. The firm presently has a “buy” rating on the healthcare company’s stock.

Receive News & Ratings for Bayer AG Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Several other equities analysts also recently commented on BAYN. UBS AG set a €125.00 ($148.81) price target on shares of Bayer AG and gave the company a “buy” rating in a research note on Tuesday, June 27th. Commerzbank Ag set a €124.00 ($147.62) price target on shares of Bayer AG and gave the company a “buy” rating in a research note on Friday, September 15th. Jefferies Group LLC set a €132.00 ($157.14) price target on shares of Bayer AG and gave the company a “buy” rating in a research note on Monday, September 18th. Warburg Research set a €121.00 ($144.05) price target on shares of Bayer AG and gave the company a “buy” rating in a research note on Wednesday, September 20th. Finally, Sanford C. Bernstein set a €128.00 ($152.38) price target on shares of Bayer AG and gave the company a “buy” rating in a research note on Monday, June 12th. Seven analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of €121.45 ($144.59).

Bayer AG (BAYN) opened at 112.554 on Monday. The company has a market capitalization of €98.16 billion and a P/E ratio of 19.470. The stock’s 50 day moving average is €108.12 and its 200-day moving average is €111.37. Bayer AG has a 12-month low of €85.72 and a 12-month high of €123.83.

TRADEMARK VIOLATION WARNING: “[[title]]” was first reported by [[site]] and is owned by of [[site]]. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at [[permalink]].

About Bayer AG

.